Authors

• Ye Htun Oo (ORCID: https://orcid.org/0000-0002-0495-6734)
• Amber Bozward (ORCID: https://orcid.org/0000-0001-6637-8952)
• Changhua Ji (ORCID: https://orcid.org/0000-0002-3329-6421)
• Natalia Krajewska
• Hester Franks (ORCID: https://orcid.org/0000-0001-5378-6076)
• Jessie Qian
• Melanie Lingaya (ORCID: https://orcid.org/0000-0002-9390-2315)
• Grace Wootton (ORCID: https://orcid.org/0009-0005-7641-8053)
• Stuart Astbury (ORCID: https://orcid.org/0000-0002-1919-3952)
• Edmond Atallah (ORCID: https://orcid.org/0000-0002-7341-9174)
• Steven W. Kumpf
• Thomas A. Lanz (ORCID: https://orcid.org/0000-0003-2483-3122)
• Mark Sheehan (ORCID: https://orcid.org/0009-0007-4916-796X)
• Ankit Rao (ORCID: https://orcid.org/0000-0003-2403-3264)
• Shashi K. Ramaiah (ORCID: https://orcid.org/0009-0007-9105-9970)
• Mar Riveiro-Barciela
• Scott P. Davies
• Flavia Radulescu
• Lourdes Ruiz-Ortega
• Jane I Grove
• Davor Kresnik
• Guruprasad P Aithal
• Poulam M Patel

Institutions

• Universitat Autònoma de Barcelona (ES)
• University Hospitals Birmingham NHS Foundation Trust (GB)
• Nottingham University Hospitals NHS Trust (GB)
• University of Nottingham (GB)
• Pfizer (United States) (US)
• NIHR Nottingham Digestive Diseases Biomedical Research Unit (GB)
• Vall d'Hebron Hospital Universitari (ES)
• NIHR Surgical Reconstruction and Microbiology Research Centre (GB)
• Nottingham Biomedical Research Centre (GB)
• NIHR Birmingham Biomedical Research Centre (GB)
• University of Birmingham (GB)

Publication Details

Journal

Journal for ImmunoTherapy of Cancer

Published

2026-03-01

DOI

https://doi.org/10.1136/jitc-2025-014178

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

0.00